Strides Pharma Science Limited has intimated the stock exchanges under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding its participation in an Analyst/Institutional Investor's Meeting.
The company will participate in a Non-Deal Road Show hosted by DAM Capital on June 12, 2026. The meeting will commence at 10:00 hrs and continue onwards. The mode of meeting is in-person and will be conducted as One-on-One sessions. The location of the meeting is Mumbai, India.
The discussion during this meeting will be based on the Earnings Presentation of Q4 FY26, which has already been intimated to and uploaded on the Stock Exchanges and the Company website.